Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Its primary approved indication in the United States is the reduction of excess abdominal fat in HIV-positive adults with lipodystrophy, a condition characterised by abnormal fat redistribution often associated with antiretroviral therapy
Participants received weekly subcutaneous injections and maintained consistent plasma concentrations throughout the dosing period
Aim for 1520 minutes before eating
Lower inflammation burden Excess body fat contributes to systemic inflammation
For researchers interested in exploring the potential of GHK-Cu, high-quality research materials are essential.
US$ 27.76
US$ 27.16
US$ 26.28
US$ 28.89
US$ 24.52
US$ 26.09
